Counties with formal ICE contracts saw higher rates of HIV among Latinos following anti-immigrant policy changes.

HIV isn’t a crime. Outdated laws are. U=U and PrEP have changed the science—now it’s time to stop criminalizing people living with HIV.

Juanita Peralta has found wisdom, peace and even joy aging with HIV.

AIDS Drug Assistance Programs are again in need of grassroots patient advocacy.

STAIR-HIV is the second study to enroll participants through ACTG’s Small Clinical Trials Advancing HIV Remission and Cure program.

The single-tablet regimen containing bictegravir and lenacapavir is a new option for people switching from complex antiretroviral regimens.

For people living with the virus, knowing how to access treatment and cover visits with providers is more important than ever.

Taking an antibiotic after sex lowered risk of chlamydia and syphilis in the South and in Australia, but results are mixed for gonorrhea.

Managing your HIV can also be an opportunity to focus on your overall well-being.

The Essen Patient, who also has hepatitis B, and the Kansas City Patient remain in long-term remission after transplants to treat cancer.

For people with serious illnesses, a clinical trial may offer the best hope for extending their life or improving their quality of life.

A long-term survivor, his husband and his brother build a home for the ages.

When HIV, meth and mental health collide, a multifaceted approach is beneficial.

People living with the virus are aging on their own terms.

The Essen Patient, who also has hepatitis B, and the Kansas City Patient remain in long-term remission after transplants to treat cancer.

The community health leader puts his principles and his identity front and center.

Risk factors for oral cancer include smoking, heavy alcohol consumption, having a lower CD4 count and being a heterosexual man.

Trump’s “war on science” has set back efforts to end the HIV epidemic, but the tide may be turning.

Twice-yearly PrEP makes its debut, novel HIV treatments are in the pipeline and metabolic health gets more attention.

Vaccination is recommended for all adults living with HIV regardless of age or CD4 count.

An HIV vaccine plus broadly neutralizing antibodies and an immune-stimulating drug helped control HIV after stopping antiretrovirals.

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN), that could bring an en...

Falls, often linked to the use of multiple medications, can lead to fractures, disability and death.

Advocates urge health insurers to ensure coverage of the highly effective new PrEP option.

Global HIV experts unite online to warn about massive federal budget cuts and help the public understand the benefits of HIV research.

Advocates rally on Capitol Hill and lobby legislators to save HIV funding.

Protests on Capitol Hill, DEI whiplash, dandelions and long-term survivors: Check them out at this year’s USCHA in Washington, DC.

HRF-10071 substantially reduced viral load when tested as monotherapy, and trials of combination treatment are forthcoming.

CDC head Susan Monarez reportedly clashed with RFK Jr. over vaccine policy; Demetre Daskalakis issues blistering statement.

Most people who started the long-acting injectables with a detectable viral load were able to bring their HIV under control.

Study was halted early but the novel NNRTI is now being tested with a lower dose of islatravir.

Merck’s MK-8527 could offer a long-acting HIV prevention option for people who don’t want injections.

Today I am 50. I'd be remiss if I didn't share the great news here. And here's why!

Drug-resistant gonorrhea is on the rise, but experts say benefits are worthwhile for those at high risk for sexually transmitted infections.

IAS 2025 spotlights scientific progress, funding challenges and leaders’ calls to action.

Modelling and real-world data from Africa and Latin America revealing rising HIV acquisitions, stalled treatment and fragile health systems

Today’s meds make living well with HIV more possible than ever. Here’s why starting treatment early matters.

U.S. federal guidelines have been the most comprehensive source for recommendations about HIV treatment and care.

The HIV Cure and Viral Disease Center brings together top scientists to advance HIV cure research and study other viral diseases.

In today’s political climate, LGBTQ humanity is on the line.

More than 99% of people who received Yeztugo in two large clinical trials remained HIV negative.

Despite an overall decrease in cancer incidence, malignancies linked to human papillomavirus and viral hepatitis remain a concern.

The National Agricultural Library canceled many journal subscriptions to save costs, leaving USDA staff without access.

Novel vaccine approaches are making progress, but it will likely be years before large trials show whether they can prevent HIV.